Spots Global Cancer Trial Database for valganciclovir
Every month we try and update this database with for valganciclovir cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Oral Valganciclovir Versus Valacyclovir | NCT00562770 | Chronic Lymphoc... Leukemia | Valganciclovir Valacyclovir | 16 Years - | M.D. Anderson Cancer Center | |
| Valganciclovir in Treating Patients With Classic Non-HIV-Associated Kaposi's Sarcoma | NCT00096538 | Sarcoma | valganciclovir | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| Study of Arginine Butyrate and Ganciclovir/Valganciclovir in EBV(+) Lymphoid Malignancies | NCT00917826 | EBV Lymphomas Lympho-prolifer... | Arginine Butyra... Ganciclovir Valganciclovir | 3 Years - | HemaQuest Pharmaceuticals Inc. | |
| Antiviral Treatment of Chronic Lymphocytic Leukemia | NCT01255644 | Chronic Lymphoc... | Valganciclovir | 18 Years - | Medical University of Vienna | |
| Valganciclovir in Treating Patients With Classic Non-HIV-Associated Kaposi's Sarcoma | NCT00096538 | Sarcoma | valganciclovir | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| A Clinical Trial Evaluating the Efficacy of Valganciclovir in Glioblastoma Patients | NCT04116411 | Glioblastoma Mu... | Valganciclovir ... Temozolomide 12... Radiotherapy 60... Placebo oral ta... | 18 Years - | Karolinska Institutet | |
| Valganciclovir in Treating Patients With Classic Non-HIV-Associated Kaposi's Sarcoma | NCT00096538 | Sarcoma | valganciclovir | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity | NCT00092222 | Lymphoprolifera... HHV-8 Malignancy HIV | Etoposide Interferon-alph... Rituximab Zidovudine Liposomal Doxor... Bortezomib Valganciclovir Doxorubicin Vincristine Cyclophosphamid... Filgrastim (G-C... Prednisone Sirolimus Observation Onl... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Study of Cytolytic Viral Activation Therapy (CVAT) for Recurrent/Metastatic Nasopharyngeal Carcinoma | NCT02761291 | Nasopharyngeal ... | Gemcitabine Valproic acid Valganciclovir | 20 Years - 80 Years | Chang Gung Memorial Hospital | |
| Dose Escalation & Expansion Study of Oral VRx-3996 & Valganciclovir in Subjects With EBV-Associated Lymphoid Malignancies | NCT03397706 | Epstein-Barr Vi... Lymphoprolifera... | VRx-3996 Valganciclovir | 18 Years - | Viracta Therapeutics, Inc. | |
| Nanatinostat Plus Valganciclovir in Patients With Advanced EBV+ Solid Tumors, and in Combination With Pembrolizumab in EBV+ RM-NPC | NCT05166577 | Nasopharyngeal ... EBV-Related Gas... EBV-Related Lei... EBV Related Car... EBV-Related Sar... | Nanatinostat Nanatinostat Valganciclovir Pembrolizumab | 18 Years - | Viracta Therapeutics, Inc. | |
| Oral Valganciclovir Versus Valacyclovir | NCT00562770 | Chronic Lymphoc... Leukemia | Valganciclovir Valacyclovir | 16 Years - | M.D. Anderson Cancer Center | |
| ValGanciclovir Versus ValAcyclovir for Viral Prophylaxis in Kidney Transplantation | NCT01972035 | Transplantation... Epstein-Barr Vi... Cytomegalovirus... | Valacyclovir Valganciclovir | - | University of Minnesota | |
| Antiviral Treatment of Chronic Lymphocytic Leukemia | NCT01255644 | Chronic Lymphoc... | Valganciclovir | 18 Years - | Medical University of Vienna | |
| Efficacy and Safety of Valcyte® as an add-on Therapy in Patients With Malignant Glioblastoma and Cytomegalovirus (CMV) Infection | NCT00400322 | Glioblastoma Mu... Cytomegalovirus... | Valganciclovir ... Placebo | 18 Years - | Karolinska Institutet | |
| A Clinical Trial Evaluating the Efficacy of Valganciclovir in Glioblastoma Patients | NCT04116411 | Glioblastoma Mu... | Valganciclovir ... Temozolomide 12... Radiotherapy 60... Placebo oral ta... | 18 Years - | Karolinska Institutet | |
| ValGanciclovir Versus ValAcyclovir for Viral Prophylaxis in Kidney Transplantation | NCT01972035 | Transplantation... Epstein-Barr Vi... Cytomegalovirus... | Valacyclovir Valganciclovir | - | University of Minnesota | |
| Efficacy and Safety of Valcyte® as an add-on Therapy in Patients With Malignant Glioblastoma and Cytomegalovirus (CMV) Infection | NCT00400322 | Glioblastoma Mu... Cytomegalovirus... | Valganciclovir ... Placebo | 18 Years - | Karolinska Institutet | |
| Dose Escalation & Expansion Study of Oral VRx-3996 & Valganciclovir in Subjects With EBV-Associated Lymphoid Malignancies | NCT03397706 | Epstein-Barr Vi... Lymphoprolifera... | VRx-3996 Valganciclovir | 18 Years - | Viracta Therapeutics, Inc. | |
| Valganciclovir (Valcyte) for Chronic Fatigue Syndrome Patients Who Have Elevated Antibody Titers Against Human Herpes Virus 6 (HHV-6)and Epstein-Barr Virus (EBV) | NCT00478465 | Chronic Fatigue... | valganciclovir | 18 Years - | Stanford University | |
| Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity | NCT00092222 | Lymphoprolifera... HHV-8 Malignancy HIV | Etoposide Interferon-alph... Rituximab Zidovudine Liposomal Doxor... Bortezomib Valganciclovir Doxorubicin Vincristine Cyclophosphamid... Filgrastim (G-C... Prednisone Sirolimus Observation Onl... | 18 Years - | National Institutes of Health Clinical Center (CC) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
